![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Biomagnetics Diagnostics Corp (CE) | USOTC:BMGP | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.000001 | 0.00 | 01:00:00 |
Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the completion of its full audit and financial review, which was conducted by Seale & Beers Certified Public Accounts, LLC.
"I am pleased that the audit has now been completed and that we are moving toward full reporting status with the U.S. Securities & Exchange Commission. We are excited about the future for Biomagnetics and we want to make sure all of our investors and shareholders have full transparency into our operations," commented Clayton Hardman, CEO of Biomagnetics.
About Biomagnetics Diagnostics Corp.
Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company and an acquirer of other innovative technologies. More information on Biomagnetics Diagnostics Corp. can be seen at www.biomagneticsbmgp.com.
1 Year Biomagnetics Diagnostics (CE) Chart |
1 Month Biomagnetics Diagnostics (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions